自从1972年Magnius首先发现HBeAg/抗—HBe系统以来,至今对它们的本质仍未十分明了。尤其近期,对于抗—HBe是否能做为预后良好的标志不少人提出异论。 以往,多数学者认为:HBeAg与DNA—P活性有关,HBeAg阳性的肝炎和肝硬变患者DNA—P阳性率高,在乙肝病情再度恶化以前,可以看到HBeAg和DNA—P增高的现象,因此得出结论—HBeAg持续阳性的慢性肝炎患者可发展为肝硬 Since the first discovery of HBeAg / anti-HBe systems by Magnius in 1972, their nature has so far not been well understood. Especially recently, many people have raised the question of whether anti-HBe can be a good marker of prognosis. In the past, most scholars believe that: HBeAg and DNA-P activity, HBeAg-positive patients with cirrhosis of the liver and DNA-P positive rate is high, hepatitis B condition again before worsening, you can see the HBeAg and DNA-P increased phenomenon, therefore Concluded - HBeAg-positive patients with chronic hepatitis can develop cirrhosis